{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:52Z","timestamp":1793404552948,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007606","name":"Aarhus Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012324","name":"University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016032","name":"Nederlandse Cystic Fibrosis Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016250","name":"Lietuvos Sveikatos Moksl\u0173 Universitetas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019355","name":"Sackler Faculty of Medicine, Tel-Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021548","name":"Drottning Silvias barnsjukhus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021548","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006470","name":"Aristotle University of Thessaloniki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["U1016"],"award-info":[{"award-number":["U1016"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T06:57:14Z","timestamp":1668927434000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4635-386X","authenticated-orcid":false,"given":"Eitan","family":"Kerem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-2757","authenticated-orcid":false,"given":"Annalisa","family":"Orenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Annicchiarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-5240","authenticated-orcid":false,"given":"Pavel","family":"Drevinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2022.11.001_bib0001","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcf.2011.07.004","article-title":"Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment","volume":"10","author":"Ridderberg","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136790","article-title":"Genetic adaptation of Achromobacter sp. during persistence in the lungs of cystic fibrosis patients","volume":"10","author":"Ridderberg","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2022.11.001_bib0003","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2012.10.002","article-title":"Identification and distribution of Achromobacter species in cystic fibrosis","volume":"12","author":"Spilker","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2022.11.001_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ppul.10143","article-title":"Alcaligenes infection in cystic fibrosis","volume":"34","author":"Tan","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2022.11.001_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcf.2006.05.011","article-title":"Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance","volume":"6","author":"De","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.001_bib0006","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1600-0463.2008.00995.x","article-title":"Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients","volume":"116","author":"Raso","year":"2008","journal-title":"APMIS"},{"issue":"8","key":"10.1016\/j.jcf.2022.11.001_bib0007","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10096-011-1182-5","article-title":"Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients","volume":"30","author":"Lambiase","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcf.2022.11.001_bib0008","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1513\/AnnalsATS.201701-071OC","article-title":"Clinical outcomes associated with Achromobacter","volume":"14","author":"Somayaji","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2022.11.001_bib0009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-008-0605-4","article-title":"Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients","volume":"28","author":"Spicuzza","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcf.2022.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1378\/chest.09-0132","article-title":"Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005","volume":"136","author":"Razvi","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2022.11.001_bib0011","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1600-0463.2008.00995.x","article-title":"Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients","volume":"116","author":"Raso","year":"2008","journal-title":"APMIS"},{"key":"10.1016\/j.jcf.2022.11.001_bib0012","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1128\/JCM.00494-13","article-title":"Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain","volume":"51","author":"Barrado","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2022.11.001_bib0013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/514631","article-title":"Microbiology of sputum from patients at cystic fibrosis centers in the United States","volume":"27","author":"Burns","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2022.11.001_bib0014","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1128\/JCM.05283-11","article-title":"Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients","volume":"49","author":"Pereira","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2022.11.001_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcf.2006.04.002","article-title":"Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study","volume":"5","author":"R\u00f8nne Hansen","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.001_bib0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcf.2006.05.011","article-title":"Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance","volume":"6","author":"De Baets","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2022.11.001_bib0017","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/JCM.02556-16","article-title":"Prevalence and outcomes of Achromobacter species infections in adults with cystic fibrosis: a north american cohort study","volume":"55","author":"Edwards","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2022.11.001_bib0018","unstructured":"Zolin, A., Orenti, A., Naehrlich, L., Jung, A., van Rens, J. et\u00a0al. (2020) ECFSPR Annual Report 2018."},{"key":"10.1016\/j.jcf.2022.11.001_bib0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.0.CO;2-G","article-title":"Genotype -phenotype correlations in cystic fibrosis","volume":"22","author":"Kerem","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2022.11.001_bib0020","unstructured":"https:\/\/hdr.undp.org\/en\/indicators\/137506."},{"issue":"1","key":"10.1016\/j.jcf.2022.11.001_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.001_bib0022","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"246","key":"10.1016\/j.jcf.2022.11.001_bib0023","first-page":"1","article-title":"2000 CDC growth charts for the United States: methods and development. National Centre for Health Statistics","volume":"11","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jcf.2022.11.001_bib0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"78","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.jcf.2022.11.001_bib0025","unstructured":"https:\/\/www.cff.org\/sites\/default\/files\/2021-11\/Patient-Registry-Annual-Data-Report.pdf, 2021."},{"issue":"5","key":"10.1016\/j.jcf.2022.11.001_bib0026","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/cid\/civ377","article-title":"Impact of sustained eradication of new pseudomonas aeruginosa infection on long-term outcomes in cystic fibrosis","volume":"61","author":"Mayer-Hamblett","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.jcf.2022.11.001_bib0027","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.1120577109","article-title":"Decade-long bacterial community dynamics in cystic fibrosis airways","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"10.1016\/j.jcf.2022.11.001_bib0028","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JCM.00432-15","article-title":"Rapid detection of emerging pathogens and loss of microbial diversity associated with severe lung disease in cystic fibrosis","volume":"53","author":"Flight","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2022.11.001_bib0029","first-page":"27","article-title":"Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis","author":"Talbot","year":"2016","journal-title":"Paediatr Respir Rev"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:49:32Z","timestamp":1761601772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322014102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1569199322014102"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.11.001","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}